MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Associations between balance confidence, gait, postural stability, and muscle strength in people with Parkinson’s disease

    B. Donmez Colakoglu, F.K Cekok, T. Kahraman, G. Duran, D. Yerlikaya, G. Yener, A. Genc (Izmir, Turkey)

    Objective: This study aimed to investigate the associations between balance confidence and gait difficulty, postural instability, and muscle weakness in people with Parkinson’s disease (PD).…
  • MDS Virtual Congress 2020

    Therapeutic effect of OnabotulinumtoxinA in bilateral hemifacial spasm, trigeminal neuralgia and chronic migraine in El Salvador

    J. Lopez-Castellanos, J. Lopez Contreras (Little Rock, AR, USA)

    Objective: To Evaluate the therapeutic and preventive effect of OnabotulinumtoxinA in the treatment of trigeminal neuralgia (TN) and chronic migraine (CM) in patients with bilateral…
  • MDS Virtual Congress 2020

    Effect of herbal medicine against Parkinson’s Diseases- An in silico studies

    S. Subramani, Y. Gupta, R. Sharma, P. Prasad (Gwalior, India)

    Objective: To evaluate the effect of the bioactive compounds of Gymnema sylvestre on treatment of Parkinson’s diseases. Background: Neurodegenerative diseases, such as Parkinson’s and Alzheimer’s,…
  • MDS Virtual Congress 2020

    Comparison of 123I-MIBG myocardial scintigraphy and 123I-FP-CIT SPECT between dementia with Lewy bodies and Parkinson’s disease

    Y. Asahara, S. Miyagawa, M. Suzuki (Tokyo, Japan)

    Objective: ​​​​​The objective of this study was to compare the nuclear medicine images of dementia with Lewy bodies (DLB) ​​and Parkinson's disease (PD) patients and to extract findings…
  • MDS Virtual Congress 2020

    Dyskinesia and bradykinesia severity patterns in Parkinson’s disease using a wearable sensor

    D. van Wamelen, T. Bendriss-Otiko, A. Podlewska, V. Leta, C. Lazcano Ocampo, D. Trivedi, K. Ray Chaudhuri (London, United Kingdom)

    Objective: To determine if dyskinesia and bradykinesia severity has a diurnal pattern in Parkinson’s disease (PD) using wearable sensor data. Background: Diurnal fluctuations in PD…
  • MDS Virtual Congress 2020

    The role of attention networks in walking in Parkinson’s disease

    R. Drake, G. Eskes (Halifax, NS, Canada)

    Objective: To better understand how different attention networks contribute to walking. Background: Parkinson’s disease (PD) is often characterized by effortful, fall-prone walking. PD can also…
  • MDS Virtual Congress 2020

    Object and action naming test in cognitive subtypes in nondemented patients with Parkinson´s disease

    A. Kušnírová, Z. Košutzká, M. Hajdúk, M. Králová, M. Pápayová, M. Egryová, P. Valkovič, Z. Cséfalvay (Bratislava, Slovakia)

    Objective: The aim of our study was to identify more homogenous profiles of patients with Parkinson´s disease (PD) without cognitive decline and to compare language…
  • MDS Virtual Congress 2020

    Premature Cognitive Decline in Young Veterans with mTBI: A Possible Prodromal Signature of Early Stage Parkinson’s Disease

    V. Nejtek, M. Salvatore, R. James, H. Alphonso (Fort Worth, TX, USA)

    Objective: To investigate the hypothesis that young veterans with (+) mTBI will show premature cognitive decline that is similar to executive functioning of Parkinson’s disease…
  • MDS Virtual Congress 2020

    Cognitive function and quality of life in Parkinson’s disease: A cross-sectional study

    Y.L Tang, X.L Liang, LL. Han, J.T Yu, J. Wang (Shanghai, China)

    Objective: We aimed to determine how the cognitive domains affect quality of life (QoL) in different cognitive states in PD. Background: Parkinson’s disease with mild…
  • MDS Virtual Congress 2020

    The study of the role of genetic risk factors in levodopa-induced dyskinesia development in Russian patients with Parkinson’s disease: a pilot study

    G. Akhmadeeva, I. Khidiyatova, I. Gilyazova, A. Baitimerov, G. Tayupova, R. Magzhanov (Ufa, Russian Federation)

    Objective: The aim of our study is to search for genetic risk factors for the development of motor side effects of dopaminergic therapy, such as…
  • « Previous Page
  • 1
  • …
  • 94
  • 95
  • 96
  • 97
  • 98
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley